What is Botox and What is it Made Of?

Botox is an injectable drug made from botulinum toxin type A, a toxin produced by the bacteria Clostridium botulinum. In large quantities, this toxin can cause botulism, a disease that affects the nerves. Botox has been used since the 1970s in the field of ophthalmology, and in the last 20 years, its use has expanded to several areas of health, especially dermatology. It is a protein made from botulinum toxin, which is injected into the body to block nerve signals and prevent muscles from moving.

The most common complications of Botox injections are ecchymosis and purpura, which can be minimized by compressing ice at injection sites before and after injection. Ectropion can also develop due to the local diffusion process of Botox when injected into the lower eyelids. If someone wants to try Botox, it's a good idea to talk to a healthcare provider about risks, costs, and other considerations. Botox has been used since the 1970s in the field of ophthalmology, and in the last 20 years, its use has expanded into several areas of health, especially dermatology.

For people looking to receive cosmetic Botox, the American Academy of Facial Aesthetics has a localization feature that can help. Most people find Botox less painful than other cosmetic procedures, such as chemical peels or dermabrasion. Contraindications to the use of Botox include patients with myasthenia gravis, amyotrophic lateral sclerosis, multiple sclerosis, Eaton Lambert syndrome, pregnant and lactating women, newborns and children, patients with focal and systemic infections, patients who are hypersensitive or allergic to Botox and patients who had previously underwent lower eyelid surgery. According to the American Board of Cosmetic Surgery, Botox Injections Are the Most Popular Cosmetic Procedure Nationwide.

Mitchell Brin explains that acetyl hexapeptide-8 can be an alternative botox therapy for a person who does not want to use the injection method because it can be used as a topical agent. Allergan marketed the drug and then acquired Oculinum in 1991, and changed the name to Botox in 1992. However, at that time a standard treatment approach for aesthetic use had not been established.